You know we've seen a lot of these concerted efforts over the years to drive the price down.And they usually work,it appears even this one did.But I can't recall any weaker arguements or reasons for MNKD to fail than these last three articles.I don't know if they're just getting lazy or they are running out of plausible reasons.I wouldn't be surprised if the next round centers around a possible link between Afrezza and hemorrhoids.
I think I'll run that one past Seeking Alpha,I think they might like it.
Sounds like easy money.
